| scholarly article | Q13442814 |
| P50 | author | Paul N Hopkins | Q89298573 |
| P2093 | author name string | Gordon H Williams | |
| Gail K Adler | |||
| Shelley Hurwitz | |||
| Rajesh Garg | |||
| P2860 | cites work | Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women | Q28370547 |
| Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension | Q33667283 | ||
| Human adipocytes secrete mineralocorticoid-releasing factors | Q33715978 | ||
| Body mass index predicts aldosterone production in normotensive adults on a high-salt diet | Q35597066 | ||
| Resistant hypertension and hyperaldosteronism | Q37311440 | ||
| Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines | Q37352865 | ||
| Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice | Q38353379 | ||
| Adrenal function testing | Q38974562 | ||
| Comparison of several insulin sensitivity indices derived from basal plasma insulin and glucose levels with minimal model indices. | Q42439097 | ||
| Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes | Q42804952 | ||
| Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients | Q44415971 | ||
| Genetic determinants of nonmodulating hypertension | Q44608926 | ||
| Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells | Q45235702 | ||
| Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity | Q46417707 | ||
| Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia | Q46740951 | ||
| Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. | Q51469414 | ||
| Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. | Q51561183 | ||
| -2 Adrenergic Receptor Diplotype Defines a Subset of Salt-Sensitive Hypertension | Q56111107 | ||
| Role for aldosterone in blood pressure regulation of obese adolescents | Q68863475 | ||
| Insulin sensitivity in patients with primary aldosteronism: a follow-up study | Q79844461 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | insulin resistance | Q1053470 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 1986-1990 | |
| P577 | publication date | 2010-02-03 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Aldosterone production and insulin resistance in healthy adults | |
| P478 | volume | 95 |
| Q85947879 | A randomised controlled trial evaluating the effect of potassium supplementation on vascular function and the renin-angiotensin-aldosterone system |
| Q36737227 | Abnormal aldosterone physiology and cardiometabolic risk factors |
| Q26746054 | Adipocytes, aldosterone and obesity-related hypertension |
| Q38720544 | Aldosterone Production and Signaling Dysregulation in Obesity. |
| Q41848157 | Aldosterone aggravates glucose intolerance induced by high fructose |
| Q38525979 | Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders |
| Q27016157 | Aldosterone synthase inhibition in humans |
| Q38126805 | Aldosterone synthase inhibition in hypertension |
| Q37594892 | Aldosterone synthase inhibitors in hypertension: current status and future possibilities |
| Q36935571 | Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study |
| Q37434620 | Caveolin 1 Modulates Aldosterone-Mediated Pathways of Glucose and Lipid Homeostasis |
| Q41640691 | Differential Effects of Two Antialdosterone Agents on Glycemic Control |
| Q36665733 | Differential predictors of insulin resistance in nondiabetic salt-resistant and salt-sensitive subjects. |
| Q41193776 | Dominance of the hypothalamus-pituitary-adrenal axis over the renin-angiotensin-aldosterone system is a risk factor for decreased insulin secretion |
| Q46941146 | Dysregulated aldosterone secretion in persons of African descent with endothelin-1 gene variants |
| Q51323973 | Effect of eplerenone on insulin action in essential hypertension: a randomised, controlled, crossover study. |
| Q34506054 | Effect of low salt diet on insulin resistance in salt-sensitive versus salt-resistant hypertension |
| Q43932153 | Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). |
| Q53143530 | Excess aldosterone-induced changes in insulin signaling molecules and glucose oxidation in gastrocnemius muscle of adult male rat. |
| Q51273122 | Genomic and rapid effects of aldosterone: what we know and do not know thus far. |
| Q39179187 | How does obesity affect the endocrine system? A narrative review |
| Q53700745 | Independent Association of Serum Aldosterone Level with Metabolic Syndrome and Insulin Resistance in Korean Adults. |
| Q30397875 | Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention |
| Q34565062 | Low-salt diet increases insulin resistance in healthy subjects |
| Q34168923 | Mineralocorticoid receptor antagonists and the metabolic syndrome |
| Q36560643 | Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease? |
| Q27026157 | Modulation of glucose metabolism by the renin-angiotensin-aldosterone system |
| Q28394234 | Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance |
| Q89748011 | Obesity and cardiovascular disease in women |
| Q90317854 | Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease |
| Q39013005 | Positive association between KCNJ5 rs2604204 (A/C) polymorphism and plasma aldosterone levels, but also plasma renin and angiotensin I and II levels, in newly diagnosed hypertensive Chinese: a case-control study |
| Q35916560 | RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients |
| Q53695087 | Randomized, Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Metabolic and Inflammatory Indices in HIV. |
| Q51092142 | Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity |
| Q37397057 | Safety and Antihypertensive Effect of Selara® (Eplerenone): Results from a Postmarketing Surveillance in Japan |
| Q46544840 | Serum free fatty acid levels in PCOS patients treated with glucophage, magnesium oxide and spironolactone |
| Q40425117 | Serum potassium is a predictor of incident diabetes in African Americans with normal aldosterone: the Jackson Heart Study |
| Q35021492 | The pathophysiology of hypertension in patients with obesity |
| Q35791100 | The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes |
| Q36550987 | The renin angiotensin aldosterone system and insulin resistance in humans |
| Q37833554 | The role of aldosterone in the metabolic syndrome |
| Q37261536 | The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness. |
Search more.